Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Valneva Austria GmbH
ClinicalTrials.gov Identifier:
NCT01563263
First received: March 14, 2012
Last updated: February 12, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)